Cost-effectiveness analysis of the phase 3 IMvigor130 study evaluating atezolizumab as monotherapy or combined with platinum-based chemotherapy versus chemotherapy alone in locally... by D.E. Magee, D.C. Cheung, A.E. Hird, S.S. Sridhar, N. Fallah-Rad, N.E. Fleshner, G.K. Kulkarni

Get full text